CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
Open Access
- 1 April 2020
- journal article
- research article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 52 (2), 622-633
- https://doi.org/10.4143/crt.2019.593
Abstract
Purpose 5-Fluorouracil (5-Fu) is used as a conventional chemotherapy drug in chemotherapy for patients with advanced colorectal cancer, but many patients still suffer from treatment failure due to 5-Fu resistance. Emerging observations revealed the important role of chemokine (C-X-C motif) ligand 13 (CXCL-13) in tumor microenvironment and its relationship with prognosis in patients with colorectal cancer. This study is designed to reveal the important role of CXCL-13 in causing colorectal cancer resistance to 5-Fu. Materials and Methods CXCL-13 levels of patient's serum or cell culture supernatants were measured separately by enzyme-linked immunosorbent assay. In cell assays, cell viability is detected by Cell Counting Kit-8. Therefore, the recombinant human CXCL-13 was used to simulate its high expression in cells while its antibody and siRNA were used to reduce CXCL-13 expression in cells. Results In this study, we demonstrated that CXCL-13 is associated with 5-Fu resistance by culture medium exchange experiments and cytokine arrays of colorectal cancer resistant and nonresistant cells. Clinical studies showed that CXCL-13 is highly expressed in the serum of 5-Fu-resistant patients. High levels of serum CXCL-13 also predict a worse clinical outcome. The addition of recombinant CXCL-13 cytokine resulted in 5-Fu resistance, while its antibody overcame 5-Fu resistance, and knockdown of CXCL-13 expression by siRNA also reduced 5-Fu resistance, which can be saved by added recombination CXCL-13. Conclusion These results not only identify a CXCL-13 mediated 5-Fu resistance mechanism but also provide a novel target for 5-Fu-resistant colorectal cancer in prevention and treatment strategies.Funding Information
- National Natural Science Foundation of China (81771502, 81701820)
- Natural Science Foundation of Zhejiang Province (LH19H160001)
- Department of Health of Zhejiang Province (2018KY473,2018PY0250)
This publication has 30 references indexed in Scilit:
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJCI Insight, 2013
- Mechanisms and insights into drug resistance in cancerFrontiers in Pharmacology, 2013
- ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosisGut, 2012
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Worldwide Variations in Colorectal CancerCA: A Cancer Journal for Clinicians, 2009
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerThe New England Journal of Medicine, 2000
- Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.International Journal of Oncology, 2000